The transfer of listing is often seen as a company's strategic move to align with its current financial status and investor base. For Lucid Diagnostics, this move could be perceived as a positive step in maintaining its listing status and could potentially attract a different set of investors. However, the impact on the stock price will depend on investor perception of the reasons behind the transfer.